DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

169 hedge funds and large institutions have $1.27B invested in Dicerna Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 50 increasing their positions, 40 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
169
Holders Change
+57
Holders Change %
+50.89%
% of All Funds
3.34%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
67
Increased
50
Reduced
40
Closed
9
Calls
$1.98M
Puts
$2.65M
Net Calls
-$667K
Net Calls Change
-$880K

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$72.3M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$27.8M
3
DCM
3
Driehaus Capital Management
Illinois
$21.9M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$21.6M
5
ACM
5
Aquilo Capital Management
California
$13.5M

Top Sellers

1
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$89.9M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$8.81M
3
RCM
3
RA Capital Management
Massachusetts
$0
4
BI
4
BVF Inc
California
$0
5
BM
5
Bridger Management
New York
$43.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
Susquehanna International Group
176
Susquehanna International Group
Pennsylvania
– -$386K -26,862 Closed
DekaBank Deutsche Girozentrale
177
DekaBank Deutsche Girozentrale
Germany
– -$349K -23,000 Closed
4 5 6 7
8